nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Epirubicin—pancreatic cancer	0.43	0.653	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—pancreatic cancer	0.229	0.347	CbGbCtD
Moxifloxacin—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.00178	0.24	CbGdCrCtD
Moxifloxacin—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.00125	0.168	CbGdCrCtD
Moxifloxacin—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.0012	0.162	CbGdCrCtD
Moxifloxacin—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	0.000452	0.0608	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	0.000419	0.0564	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	0.000419	0.0564	CbGdCrCtD
Moxifloxacin—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	0.000419	0.0564	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	0.000388	0.0522	CbGdCrCtD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	0.000388	0.0522	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	0.000388	0.0522	CbGdCrCtD
Moxifloxacin—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	0.000324	0.0436	CbGdCrCtD
Moxifloxacin—Anaphylactic shock—Docetaxel—pancreatic cancer	9.9e-05	0.000296	CcSEcCtD
Moxifloxacin—Weight increased—Doxorubicin—pancreatic cancer	9.88e-05	0.000296	CcSEcCtD
Moxifloxacin—Epistaxis—Epirubicin—pancreatic cancer	9.87e-05	0.000296	CcSEcCtD
Moxifloxacin—Pruritus—Gemcitabine—pancreatic cancer	9.87e-05	0.000295	CcSEcCtD
Moxifloxacin—Sinusitis—Epirubicin—pancreatic cancer	9.82e-05	0.000294	CcSEcCtD
Moxifloxacin—Hyperglycaemia—Doxorubicin—pancreatic cancer	9.8e-05	0.000293	CcSEcCtD
Moxifloxacin—Diarrhoea—Irinotecan—pancreatic cancer	9.8e-05	0.000293	CcSEcCtD
Moxifloxacin—Agranulocytosis—Epirubicin—pancreatic cancer	9.77e-05	0.000292	CcSEcCtD
Moxifloxacin—Pneumonia—Doxorubicin—pancreatic cancer	9.74e-05	0.000292	CcSEcCtD
Moxifloxacin—Shock—Docetaxel—pancreatic cancer	9.74e-05	0.000292	CcSEcCtD
Moxifloxacin—Nervous system disorder—Docetaxel—pancreatic cancer	9.71e-05	0.000291	CcSEcCtD
Moxifloxacin—Pruritus—Fluorouracil—pancreatic cancer	9.7e-05	0.00029	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Docetaxel—pancreatic cancer	9.69e-05	0.00029	CcSEcCtD
Moxifloxacin—Infestation—Doxorubicin—pancreatic cancer	9.68e-05	0.00029	CcSEcCtD
Moxifloxacin—Infestation NOS—Doxorubicin—pancreatic cancer	9.68e-05	0.00029	CcSEcCtD
Moxifloxacin—Tachycardia—Docetaxel—pancreatic cancer	9.66e-05	0.000289	CcSEcCtD
Moxifloxacin—Skin disorder—Docetaxel—pancreatic cancer	9.61e-05	0.000288	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	9.6e-05	0.000287	CcSEcCtD
Moxifloxacin—Bradycardia—Epirubicin—pancreatic cancer	9.56e-05	0.000286	CcSEcCtD
Moxifloxacin—Diarrhoea—Gemcitabine—pancreatic cancer	9.54e-05	0.000286	CcSEcCtD
Moxifloxacin—Renal failure—Doxorubicin—pancreatic cancer	9.52e-05	0.000285	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	9.49e-05	0.000284	CcSEcCtD
Moxifloxacin—Dizziness—Irinotecan—pancreatic cancer	9.47e-05	0.000283	CcSEcCtD
Moxifloxacin—Haemoglobin—Epirubicin—pancreatic cancer	9.44e-05	0.000283	CcSEcCtD
Moxifloxacin—Stomatitis—Doxorubicin—pancreatic cancer	9.44e-05	0.000283	CcSEcCtD
Moxifloxacin—Jaundice—Doxorubicin—pancreatic cancer	9.44e-05	0.000283	CcSEcCtD
Moxifloxacin—Anorexia—Docetaxel—pancreatic cancer	9.43e-05	0.000282	CcSEcCtD
Moxifloxacin—Rhinitis—Epirubicin—pancreatic cancer	9.42e-05	0.000282	CcSEcCtD
Moxifloxacin—Conjunctivitis—Doxorubicin—pancreatic cancer	9.41e-05	0.000282	CcSEcCtD
Moxifloxacin—Urinary tract infection—Doxorubicin—pancreatic cancer	9.41e-05	0.000282	CcSEcCtD
Moxifloxacin—Hepatitis—Epirubicin—pancreatic cancer	9.4e-05	0.000281	CcSEcCtD
Moxifloxacin—Haemorrhage—Epirubicin—pancreatic cancer	9.4e-05	0.000281	CcSEcCtD
Moxifloxacin—Diarrhoea—Fluorouracil—pancreatic cancer	9.38e-05	0.000281	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Epirubicin—pancreatic cancer	9.35e-05	0.00028	CcSEcCtD
Moxifloxacin—Pharyngitis—Epirubicin—pancreatic cancer	9.32e-05	0.000279	CcSEcCtD
Moxifloxacin—Sweating—Doxorubicin—pancreatic cancer	9.28e-05	0.000278	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Epirubicin—pancreatic cancer	9.28e-05	0.000278	CcSEcCtD
Moxifloxacin—Oedema peripheral—Epirubicin—pancreatic cancer	9.26e-05	0.000277	CcSEcCtD
Moxifloxacin—Hypotension—Docetaxel—pancreatic cancer	9.25e-05	0.000277	CcSEcCtD
Moxifloxacin—Haematuria—Doxorubicin—pancreatic cancer	9.23e-05	0.000276	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Epirubicin—pancreatic cancer	9.23e-05	0.000276	CcSEcCtD
Moxifloxacin—Urethral disorder—Epirubicin—pancreatic cancer	9.21e-05	0.000276	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	9.16e-05	0.000274	CcSEcCtD
Moxifloxacin—Epistaxis—Doxorubicin—pancreatic cancer	9.13e-05	0.000273	CcSEcCtD
Moxifloxacin—Vomiting—Irinotecan—pancreatic cancer	9.1e-05	0.000273	CcSEcCtD
Moxifloxacin—Sinusitis—Doxorubicin—pancreatic cancer	9.09e-05	0.000272	CcSEcCtD
Moxifloxacin—Dizziness—Fluorouracil—pancreatic cancer	9.07e-05	0.000271	CcSEcCtD
Moxifloxacin—Visual impairment—Epirubicin—pancreatic cancer	9.05e-05	0.000271	CcSEcCtD
Moxifloxacin—Agranulocytosis—Doxorubicin—pancreatic cancer	9.04e-05	0.000271	CcSEcCtD
Moxifloxacin—Rash—Irinotecan—pancreatic cancer	9.03e-05	0.00027	CcSEcCtD
Moxifloxacin—Dermatitis—Irinotecan—pancreatic cancer	9.02e-05	0.00027	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.02e-05	0.00027	CcSEcCtD
Moxifloxacin—Headache—Irinotecan—pancreatic cancer	8.97e-05	0.000269	CcSEcCtD
Moxifloxacin—Insomnia—Docetaxel—pancreatic cancer	8.95e-05	0.000268	CcSEcCtD
Moxifloxacin—Paraesthesia—Docetaxel—pancreatic cancer	8.89e-05	0.000266	CcSEcCtD
Moxifloxacin—Erythema multiforme—Epirubicin—pancreatic cancer	8.88e-05	0.000266	CcSEcCtD
Moxifloxacin—Vomiting—Gemcitabine—pancreatic cancer	8.87e-05	0.000265	CcSEcCtD
Moxifloxacin—Bradycardia—Doxorubicin—pancreatic cancer	8.85e-05	0.000265	CcSEcCtD
Moxifloxacin—Dyspnoea—Docetaxel—pancreatic cancer	8.82e-05	0.000264	CcSEcCtD
Moxifloxacin—Somnolence—Docetaxel—pancreatic cancer	8.8e-05	0.000263	CcSEcCtD
Moxifloxacin—Rash—Gemcitabine—pancreatic cancer	8.79e-05	0.000263	CcSEcCtD
Moxifloxacin—Dermatitis—Gemcitabine—pancreatic cancer	8.78e-05	0.000263	CcSEcCtD
Moxifloxacin—Eye disorder—Epirubicin—pancreatic cancer	8.78e-05	0.000263	CcSEcCtD
Moxifloxacin—Tinnitus—Epirubicin—pancreatic cancer	8.76e-05	0.000262	CcSEcCtD
Moxifloxacin—Haemoglobin—Doxorubicin—pancreatic cancer	8.74e-05	0.000262	CcSEcCtD
Moxifloxacin—Headache—Gemcitabine—pancreatic cancer	8.74e-05	0.000262	CcSEcCtD
Moxifloxacin—Cardiac disorder—Epirubicin—pancreatic cancer	8.72e-05	0.000261	CcSEcCtD
Moxifloxacin—Vomiting—Fluorouracil—pancreatic cancer	8.72e-05	0.000261	CcSEcCtD
Moxifloxacin—Rhinitis—Doxorubicin—pancreatic cancer	8.72e-05	0.000261	CcSEcCtD
Moxifloxacin—Dyspepsia—Docetaxel—pancreatic cancer	8.71e-05	0.000261	CcSEcCtD
Moxifloxacin—Haemorrhage—Doxorubicin—pancreatic cancer	8.69e-05	0.00026	CcSEcCtD
Moxifloxacin—Hepatitis—Doxorubicin—pancreatic cancer	8.69e-05	0.00026	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—pancreatic cancer	8.65e-05	0.000259	CcSEcCtD
Moxifloxacin—Rash—Fluorouracil—pancreatic cancer	8.65e-05	0.000259	CcSEcCtD
Moxifloxacin—Dermatitis—Fluorouracil—pancreatic cancer	8.64e-05	0.000259	CcSEcCtD
Moxifloxacin—Pharyngitis—Doxorubicin—pancreatic cancer	8.63e-05	0.000258	CcSEcCtD
Moxifloxacin—Decreased appetite—Docetaxel—pancreatic cancer	8.6e-05	0.000258	CcSEcCtD
Moxifloxacin—Headache—Fluorouracil—pancreatic cancer	8.59e-05	0.000257	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—pancreatic cancer	8.59e-05	0.000257	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—pancreatic cancer	8.56e-05	0.000256	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	8.54e-05	0.000256	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—pancreatic cancer	8.54e-05	0.000256	CcSEcCtD
Moxifloxacin—Fatigue—Docetaxel—pancreatic cancer	8.53e-05	0.000255	CcSEcCtD
Moxifloxacin—Angiopathy—Epirubicin—pancreatic cancer	8.52e-05	0.000255	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—pancreatic cancer	8.52e-05	0.000255	CcSEcCtD
Moxifloxacin—Nausea—Irinotecan—pancreatic cancer	8.5e-05	0.000255	CcSEcCtD
Moxifloxacin—Immune system disorder—Epirubicin—pancreatic cancer	8.49e-05	0.000254	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Epirubicin—pancreatic cancer	8.47e-05	0.000254	CcSEcCtD
Moxifloxacin—Constipation—Docetaxel—pancreatic cancer	8.46e-05	0.000253	CcSEcCtD
Moxifloxacin—Pain—Docetaxel—pancreatic cancer	8.46e-05	0.000253	CcSEcCtD
Moxifloxacin—Chills—Epirubicin—pancreatic cancer	8.43e-05	0.000252	CcSEcCtD
Moxifloxacin—Arrhythmia—Epirubicin—pancreatic cancer	8.39e-05	0.000251	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—pancreatic cancer	8.38e-05	0.000251	CcSEcCtD
Moxifloxacin—Nausea—Gemcitabine—pancreatic cancer	8.28e-05	0.000248	CcSEcCtD
Moxifloxacin—Mental disorder—Epirubicin—pancreatic cancer	8.23e-05	0.000246	CcSEcCtD
Moxifloxacin—Erythema multiforme—Doxorubicin—pancreatic cancer	8.22e-05	0.000246	CcSEcCtD
Moxifloxacin—Erythema—Epirubicin—pancreatic cancer	8.18e-05	0.000245	CcSEcCtD
Moxifloxacin—Malnutrition—Epirubicin—pancreatic cancer	8.18e-05	0.000245	CcSEcCtD
Moxifloxacin—Feeling abnormal—Docetaxel—pancreatic cancer	8.16e-05	0.000244	CcSEcCtD
Moxifloxacin—Nausea—Fluorouracil—pancreatic cancer	8.14e-05	0.000244	CcSEcCtD
Moxifloxacin—Eye disorder—Doxorubicin—pancreatic cancer	8.12e-05	0.000243	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—pancreatic cancer	8.11e-05	0.000243	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.09e-05	0.000242	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—pancreatic cancer	8.07e-05	0.000242	CcSEcCtD
Moxifloxacin—Flatulence—Epirubicin—pancreatic cancer	8.06e-05	0.000241	CcSEcCtD
Moxifloxacin—Tension—Epirubicin—pancreatic cancer	8.03e-05	0.00024	CcSEcCtD
Moxifloxacin—Dysgeusia—Epirubicin—pancreatic cancer	8.01e-05	0.00024	CcSEcCtD
Moxifloxacin—Nervousness—Epirubicin—pancreatic cancer	7.94e-05	0.000238	CcSEcCtD
Moxifloxacin—Back pain—Epirubicin—pancreatic cancer	7.91e-05	0.000237	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—pancreatic cancer	7.89e-05	0.000236	CcSEcCtD
Moxifloxacin—Muscle spasms—Epirubicin—pancreatic cancer	7.86e-05	0.000235	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—pancreatic cancer	7.85e-05	0.000235	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—pancreatic cancer	7.83e-05	0.000235	CcSEcCtD
Moxifloxacin—Body temperature increased—Docetaxel—pancreatic cancer	7.82e-05	0.000234	CcSEcCtD
Moxifloxacin—Abdominal pain—Docetaxel—pancreatic cancer	7.82e-05	0.000234	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—pancreatic cancer	7.8e-05	0.000234	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—pancreatic cancer	7.77e-05	0.000233	CcSEcCtD
Moxifloxacin—Vision blurred—Epirubicin—pancreatic cancer	7.71e-05	0.000231	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—pancreatic cancer	7.62e-05	0.000228	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Epirubicin—pancreatic cancer	7.59e-05	0.000227	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—pancreatic cancer	7.57e-05	0.000227	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—pancreatic cancer	7.57e-05	0.000227	CcSEcCtD
Moxifloxacin—Anaemia—Epirubicin—pancreatic cancer	7.56e-05	0.000226	CcSEcCtD
Moxifloxacin—Agitation—Epirubicin—pancreatic cancer	7.52e-05	0.000225	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—pancreatic cancer	7.46e-05	0.000223	CcSEcCtD
Moxifloxacin—Tension—Doxorubicin—pancreatic cancer	7.43e-05	0.000222	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—pancreatic cancer	7.41e-05	0.000222	CcSEcCtD
Moxifloxacin—Malaise—Epirubicin—pancreatic cancer	7.38e-05	0.000221	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—pancreatic cancer	7.35e-05	0.00022	CcSEcCtD
Moxifloxacin—Vertigo—Epirubicin—pancreatic cancer	7.35e-05	0.00022	CcSEcCtD
Moxifloxacin—Syncope—Epirubicin—pancreatic cancer	7.33e-05	0.00022	CcSEcCtD
Moxifloxacin—Leukopenia—Epirubicin—pancreatic cancer	7.32e-05	0.000219	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—pancreatic cancer	7.32e-05	0.000219	CcSEcCtD
Moxifloxacin—Hypersensitivity—Docetaxel—pancreatic cancer	7.29e-05	0.000218	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—pancreatic cancer	7.28e-05	0.000218	CcSEcCtD
Moxifloxacin—Palpitations—Epirubicin—pancreatic cancer	7.23e-05	0.000216	CcSEcCtD
Moxifloxacin—Loss of consciousness—Epirubicin—pancreatic cancer	7.19e-05	0.000215	CcSEcCtD
Moxifloxacin—Cough—Epirubicin—pancreatic cancer	7.14e-05	0.000214	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—pancreatic cancer	7.13e-05	0.000214	CcSEcCtD
Moxifloxacin—Asthenia—Docetaxel—pancreatic cancer	7.1e-05	0.000213	CcSEcCtD
Moxifloxacin—Convulsion—Epirubicin—pancreatic cancer	7.09e-05	0.000212	CcSEcCtD
Moxifloxacin—Hypertension—Epirubicin—pancreatic cancer	7.06e-05	0.000211	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.02e-05	0.00021	CcSEcCtD
Moxifloxacin—Pruritus—Docetaxel—pancreatic cancer	7e-05	0.00021	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—pancreatic cancer	6.99e-05	0.000209	CcSEcCtD
Moxifloxacin—Arthralgia—Epirubicin—pancreatic cancer	6.96e-05	0.000208	CcSEcCtD
Moxifloxacin—Chest pain—Epirubicin—pancreatic cancer	6.96e-05	0.000208	CcSEcCtD
Moxifloxacin—Myalgia—Epirubicin—pancreatic cancer	6.96e-05	0.000208	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—pancreatic cancer	6.95e-05	0.000208	CcSEcCtD
Moxifloxacin—Anxiety—Epirubicin—pancreatic cancer	6.94e-05	0.000208	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.92e-05	0.000207	CcSEcCtD
Moxifloxacin—Discomfort—Epirubicin—pancreatic cancer	6.88e-05	0.000206	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—pancreatic cancer	6.82e-05	0.000204	CcSEcCtD
Moxifloxacin—Dry mouth—Epirubicin—pancreatic cancer	6.81e-05	0.000204	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—pancreatic cancer	6.8e-05	0.000204	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—pancreatic cancer	6.79e-05	0.000203	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—pancreatic cancer	6.77e-05	0.000203	CcSEcCtD
Moxifloxacin—Diarrhoea—Docetaxel—pancreatic cancer	6.77e-05	0.000203	CcSEcCtD
Moxifloxacin—Confusional state—Epirubicin—pancreatic cancer	6.73e-05	0.000202	CcSEcCtD
Moxifloxacin—Palpitations—Doxorubicin—pancreatic cancer	6.69e-05	0.0002	CcSEcCtD
Moxifloxacin—Oedema—Epirubicin—pancreatic cancer	6.68e-05	0.0002	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Epirubicin—pancreatic cancer	6.68e-05	0.0002	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—pancreatic cancer	6.65e-05	0.000199	CcSEcCtD
Moxifloxacin—Cough—Doxorubicin—pancreatic cancer	6.6e-05	0.000198	CcSEcCtD
Moxifloxacin—Shock—Epirubicin—pancreatic cancer	6.57e-05	0.000197	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—pancreatic cancer	6.56e-05	0.000196	CcSEcCtD
Moxifloxacin—Nervous system disorder—Epirubicin—pancreatic cancer	6.55e-05	0.000196	CcSEcCtD
Moxifloxacin—Dizziness—Docetaxel—pancreatic cancer	6.54e-05	0.000196	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Epirubicin—pancreatic cancer	6.54e-05	0.000196	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—pancreatic cancer	6.53e-05	0.000196	CcSEcCtD
Moxifloxacin—Tachycardia—Epirubicin—pancreatic cancer	6.51e-05	0.000195	CcSEcCtD
Moxifloxacin—Skin disorder—Epirubicin—pancreatic cancer	6.48e-05	0.000194	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Epirubicin—pancreatic cancer	6.45e-05	0.000193	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—pancreatic cancer	6.44e-05	0.000193	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—pancreatic cancer	6.44e-05	0.000193	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—pancreatic cancer	6.44e-05	0.000193	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—pancreatic cancer	6.42e-05	0.000192	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.4e-05	0.000192	CcSEcCtD
Moxifloxacin—Discomfort—Doxorubicin—pancreatic cancer	6.37e-05	0.000191	CcSEcCtD
Moxifloxacin—Anorexia—Epirubicin—pancreatic cancer	6.36e-05	0.000191	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—pancreatic cancer	6.3e-05	0.000189	CcSEcCtD
Moxifloxacin—Vomiting—Docetaxel—pancreatic cancer	6.29e-05	0.000188	CcSEcCtD
Moxifloxacin—Rash—Docetaxel—pancreatic cancer	6.24e-05	0.000187	CcSEcCtD
Moxifloxacin—Hypotension—Epirubicin—pancreatic cancer	6.24e-05	0.000187	CcSEcCtD
Moxifloxacin—Dermatitis—Docetaxel—pancreatic cancer	6.23e-05	0.000187	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—pancreatic cancer	6.23e-05	0.000186	CcSEcCtD
Moxifloxacin—Headache—Docetaxel—pancreatic cancer	6.2e-05	0.000186	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—pancreatic cancer	6.18e-05	0.000185	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.18e-05	0.000185	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.08e-05	0.000182	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—pancreatic cancer	6.08e-05	0.000182	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—pancreatic cancer	6.06e-05	0.000181	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.05e-05	0.000181	CcSEcCtD
Moxifloxacin—Insomnia—Epirubicin—pancreatic cancer	6.04e-05	0.000181	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—pancreatic cancer	6.03e-05	0.00018	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—pancreatic cancer	6e-05	0.00018	CcSEcCtD
Moxifloxacin—Paraesthesia—Epirubicin—pancreatic cancer	5.99e-05	0.000179	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.97e-05	0.000179	CcSEcCtD
Moxifloxacin—Dyspnoea—Epirubicin—pancreatic cancer	5.95e-05	0.000178	CcSEcCtD
Moxifloxacin—Somnolence—Epirubicin—pancreatic cancer	5.93e-05	0.000178	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—pancreatic cancer	5.89e-05	0.000176	CcSEcCtD
Moxifloxacin—Nausea—Docetaxel—pancreatic cancer	5.88e-05	0.000176	CcSEcCtD
Moxifloxacin—Dyspepsia—Epirubicin—pancreatic cancer	5.88e-05	0.000176	CcSEcCtD
Moxifloxacin—Decreased appetite—Epirubicin—pancreatic cancer	5.8e-05	0.000174	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—pancreatic cancer	5.77e-05	0.000173	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.76e-05	0.000173	CcSEcCtD
Moxifloxacin—Fatigue—Epirubicin—pancreatic cancer	5.75e-05	0.000172	CcSEcCtD
Moxifloxacin—Constipation—Epirubicin—pancreatic cancer	5.71e-05	0.000171	CcSEcCtD
Moxifloxacin—Pain—Epirubicin—pancreatic cancer	5.71e-05	0.000171	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.63e-05	0.000168	CcSEcCtD
Moxifloxacin—Insomnia—Doxorubicin—pancreatic cancer	5.59e-05	0.000167	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—pancreatic cancer	5.55e-05	0.000166	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—pancreatic cancer	5.51e-05	0.000165	CcSEcCtD
Moxifloxacin—Feeling abnormal—Epirubicin—pancreatic cancer	5.5e-05	0.000165	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—pancreatic cancer	5.49e-05	0.000164	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.46e-05	0.000163	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—pancreatic cancer	5.44e-05	0.000163	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—pancreatic cancer	5.37e-05	0.000161	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.33e-05	0.00016	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—pancreatic cancer	5.32e-05	0.000159	CcSEcCtD
Moxifloxacin—Urticaria—Epirubicin—pancreatic cancer	5.3e-05	0.000159	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—pancreatic cancer	5.28e-05	0.000158	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—pancreatic cancer	5.28e-05	0.000158	CcSEcCtD
Moxifloxacin—Abdominal pain—Epirubicin—pancreatic cancer	5.28e-05	0.000158	CcSEcCtD
Moxifloxacin—Body temperature increased—Epirubicin—pancreatic cancer	5.28e-05	0.000158	CcSEcCtD
Moxifloxacin—Feeling abnormal—Doxorubicin—pancreatic cancer	5.09e-05	0.000152	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.05e-05	0.000151	CcSEcCtD
Moxifloxacin—Hypersensitivity—Epirubicin—pancreatic cancer	4.92e-05	0.000147	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—pancreatic cancer	4.91e-05	0.000147	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—pancreatic cancer	4.88e-05	0.000146	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—pancreatic cancer	4.88e-05	0.000146	CcSEcCtD
Moxifloxacin—Asthenia—Epirubicin—pancreatic cancer	4.79e-05	0.000143	CcSEcCtD
Moxifloxacin—Pruritus—Epirubicin—pancreatic cancer	4.72e-05	0.000141	CcSEcCtD
Moxifloxacin—Diarrhoea—Epirubicin—pancreatic cancer	4.57e-05	0.000137	CcSEcCtD
Moxifloxacin—Hypersensitivity—Doxorubicin—pancreatic cancer	4.55e-05	0.000136	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—pancreatic cancer	4.43e-05	0.000133	CcSEcCtD
Moxifloxacin—Dizziness—Epirubicin—pancreatic cancer	4.41e-05	0.000132	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—pancreatic cancer	4.37e-05	0.000131	CcSEcCtD
Moxifloxacin—Vomiting—Epirubicin—pancreatic cancer	4.24e-05	0.000127	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—pancreatic cancer	4.23e-05	0.000127	CcSEcCtD
Moxifloxacin—Rash—Epirubicin—pancreatic cancer	4.21e-05	0.000126	CcSEcCtD
Moxifloxacin—Dermatitis—Epirubicin—pancreatic cancer	4.2e-05	0.000126	CcSEcCtD
Moxifloxacin—Headache—Epirubicin—pancreatic cancer	4.18e-05	0.000125	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—pancreatic cancer	4.08e-05	0.000122	CcSEcCtD
Moxifloxacin—Nausea—Epirubicin—pancreatic cancer	3.96e-05	0.000119	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—pancreatic cancer	3.93e-05	0.000118	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—pancreatic cancer	3.89e-05	0.000117	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—pancreatic cancer	3.89e-05	0.000116	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—pancreatic cancer	3.87e-05	0.000116	CcSEcCtD
Moxifloxacin—Nausea—Doxorubicin—pancreatic cancer	3.67e-05	0.00011	CcSEcCtD
